Hyperprolactinaemia due to hypothalamic-pituitary disease or drug-induced in patients with erectile dysfunction

Andrologia
M S VenetikouD Gizani

Abstract

One hundred and sixty-five patients with erectile dysfunction were assessed at the Athens Medical Sex Institute: 60 men (36.4%) considered their condition as organic, 52 (31.5%) rated it as mostly psychogenic, 45 (27.2%) thought it could be of mixed aetiology and 8 (4.8%) could not comment at all as to the aetiology. Initial psychologic evaluation rated the condition in the majority of cases as psychogenic (130 patients, 84.8%). No psychologist considered the erectile dysfunction as purely (100%) organic. After the urological and endocrine evaluation, vascular disorder was considered in 30 patients (18.2%), endocrine dysfunction in 16 patients (9.7%) and psychogenic in 109 patients (66.1%). Sixteen of the above patients had definite hyperprolactinaemia, two had large-sized prolactinomas as revealed by magnetic resonance imaging (MRI) and pituitary function tests. Four had nonfunctioning pituitary tumours, which was also based on MRI and pituitary tests. Four had small prolactin (PRL) adenomas. Drug-induced hyperprolactinaemia was suspected in six patients who used medications affecting PRL secretion and had no evidence of tumour on radiological evaluation. In conclusion, hyperprolactinaemia in men with erectile dysfunction need...Continue Reading

References

Jan 1, 1988·Archives of Andrology·A el-BeheiryK el-Sabah
Jan 1, 1985·Hormone Research·J BuvatP Fossati
Nov 1, 1983·Clinics in Endocrinology and Metabolism·S Franks, H S Jacobs
Feb 22, 1980·JAMA : the Journal of the American Medical Association·R F SparkP B Connolly
Jun 1, 1994·Journal of General Internal Medicine·B E AkpunonuL S Woldenberg
Apr 7, 1998·Human Reproduction Update·A FabbriA Isidori
Nov 18, 1998·Mayo Clinic Proceedings·R D Calle-RodrigueD H Davis
May 8, 1999·The Diabetes Educator·G R Spollett
Jul 10, 1999·Drugs·H D Langtry, A Markham
Sep 1, 1999·International Journal of Impotence Research·D CaspariH Derouet
Sep 30, 1999·The Medical Clinics of North America·F E Kaiser
Jan 6, 2000·Hospital Medicine·M H Cummings, W D Alexander
Mar 16, 2000·Clinical Endocrinology·A LevyC Gingell
Jun 15, 2000·The New England Journal of Medicine·T F Lue
Aug 30, 2001·International Journal of Impotence Research·A M JohriA Morales
Aug 16, 2002·European Urology·Emre AkkusUNKNOWN Turkish Erectile Dysfunction Prevalence Study Group
Feb 28, 2003·International Journal of Impotence Research·Benjamin D Sachs
Jul 5, 2003·Current Medical Research and Opinion·Andrea SaloniaFrancesco Montorsi
May 28, 2004·International Journal of Impotence Research·G CoronaM Maggi
Aug 12, 2005·Mayo Clinic Proceedings·Mark E Molitch
Jan 18, 2006·Pituitary·Antonio CiccarelliAnnamaria Colao
Jun 20, 2006·International Journal of Clinical Practice·P J Wright
Jul 28, 2007·International Journal of Clinical Practice·W J G Hellstrom

❮ Previous
Next ❯

Citations

Jun 9, 2011·The Journal of Clinical Hypertension·Joel Handler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.